Skip to main content
. 2014 May;8(3):458–465. doi: 10.1177/1932296814529988

Figure 3.

Figure 3.

Results of systematic literature survey. The graph displays the general proportion of preclinical and clinical data published on oral insulin as well as the distribution of indications among clinical trials. Besides insulin substitution therapy, oral insulin has been investigated as pharmaceutical prophylaxis for type 1 diabetes as well as for another nondiabetic condition (pediatric short bowel disease).